Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06378190
Status:
RECRUITING
Last Update Posted:
2024-06-03
First Post:
2024-02-16
Brief Title:
Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor CAR T-cell Therapy Produced by a New Technology
Sponsor:
Organization:
Instituto de Investigación Biomédica de Salamanca